Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07038902
Active, not recruiting Not applicable

A Comparative Study Between Modified Miniscrew-Assisted Rapid Palatal Expander And Modified Rapid Palatal Expander in Molar Distalization Using Cone- Beam Computed Tomography

NCT07038902 · tracked via the Priya Life Science Egypt tracker
Sponsor
Al-Azhar University
Phase
Not applicable
Started
2025-11-01
Last updated
2025-12-24

Condition(s) studied

Malocclusion, Class I/IICrowdingMaxillary First Molar Distalization

Investigational drug(s) / intervention(s)

Group A: Modified Miniscrew-Assisted Rapid Palatal Expander (MARPE)Group B: Modified Rapid Palatal Expander (RPE)

Group A: Modified Miniscrew-Assisted Rapid Palatal Expander (MARPE): A skeletal anchorage-supported with miniscrews inserted into the palate using a self-drilling technique.

Group B: Modified Rapid Palatal Expander (RPE): A tooth-borne anchorage focusing on molar distalization .

Study summary

Comparative study between modified miniscrew-assisted rapid palatal expander and modified rapid palatal expander in molar distalization using CBCT.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Presence of permanent dentition * Skeletal Class I * Dental Class II molar relationship with moderate dental crowding * Crowding \>4mm * Good oral hygiene * Healthy periodontal condition Exclusion Criteria: * Presence of craniofacial syndromes or cleft palate * History of previous orthodontic treatment * Poor oral hygiene or active periodontal disease * Contraindications to CBCT imaging (e.g., pregnancy, inability to remain still during the scan)

Primary outcome measure(s)

  • Amount of Molar Distalization Measured by CBCT — Baseline (prior to initiation of molar distalization) At the end of the molar distalization phase (approximately 12 weeks post-treatment initiation).

Trial sites (1)

FacilityCityRegionStatus
Department of Orthodontics, Faculty of Dental Medicine, Al-Azhar University, Assiut branch. Asyut Egypt

More Al-Azhar University trials in Egypt

Evaluation of Different Attachments on Implant-Retained Mandibular Overdenture. Recruiting
Impact of Various Acceleration Techniques on En-masse Retraction of Maxillary Anterior Teeth Starting soon
Ultrasound-Guided Microwave Ablation for Breast Fibroadenoma: Safety and Cosmetic Outcomes Starting soon
Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients Starting soon
Artificial Intelligence for the Diagnosis of Gingivitis Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07038902 on ClinicalTrials.gov ↗ ← All trials in Egypt